Trichorovin-VIIa
| Internal ID | 17093314-db6d-45a4-a131-28ef90479189 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[(2-acetamido-2-methylpropanoyl)amino]-N-[1-[[1-[[1-[2-[[1-[[1-[[1-[2-[(1-hydroxy-4-methylpentan-2-yl)carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]butanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C57H100N12O13/c1-30(2)24-36(29-70)59-49(77)41-20-18-22-68(41)53(81)56(14,15)66-48(76)39(27-33(7)8)61-45(73)37(25-31(3)4)62-50(78)42-21-19-23-69(42)54(82)57(16,17)67-51(79)44(34(9)10)64-47(75)38(26-32(5)6)60-46(74)40(28-43(58)72)63-52(80)55(12,13)65-35(11)71/h30-34,36-42,44,70H,18-29H2,1-17H3,(H2,58,72)(H,59,77)(H,60,74)(H,61,73)(H,62,78)(H,63,80)(H,64,75)(H,65,71)(H,66,76)(H,67,79) |
| InChI Key | RQKYLSAUQCAMJL-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C57H100N12O13 |
| Molecular Weight | 1161.50 g/mol |
| Exact Mass | 1160.75328129 g/mol |
| Topological Polar Surface Area (TPSA) | 366.00 Ų |
| XlogP | 2.70 |
| Atomic LogP (AlogP) | 0.29 |
| H-Bond Acceptor | 13 |
| H-Bond Donor | 11 |
| Rotatable Bonds | 31 |
| RefChem:191256 |
| 2-((1-hydroxy-2-((1-hydroxyethylidene)amino)-2-methylpropylidene)amino)-N-(1-((1-((1-(2-((1-((1-((1-(2-((1-hydroxy-4-methylpentan-2-yl)-C-hydroxycarbonimidoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl)-3-methylbutyl)-C-hydroxycarbonimidoyl)-3-methylbutyl)-C-hydroxycarbonimidoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl)-2-methylpropyl)-C-hydroxycarbonimidoyl)-3-methylbutyl)butanediimidate |
| 2-((2-acetamido-2-methylpropanoyl)amino)-N-(1-((1-((1-(2-((1-((1-((1-(2-((1-hydroxy-4-methylpentan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)butanediamide |
| 2-({1-hydroxy-2-[(1-hydroxyethylidene)amino]-2-methylpropylidene}amino)-N-{1-[(1-{[1-(2-{[1-({1-[(1-{2-[(1-hydroxy-4-methylpentan-2-yl)-C-hydroxycarbonimidoyl]pyrrolidin-1-yl}-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl]-3-methylbutyl}-C-hydroxycarbonimidoyl)-3-methylbutyl]-C-hydroxycarbonimidoyl}pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl]-C-hydroxycarbonimidoyl}-2-methylpropyl)-C-hydroxycarbonimidoyl]-3-methylbutyl}butanediimidate |
| 2-[(2-acetamido-2-methylpropanoyl)amino]-N-[1-[[1-[[1-[2-[[1-[[1-[[1-[2-[(1-hydroxy-4-methylpentan-2-yl)carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]butanediamide |
| CHEBI:205055 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5464 | 54.64% |
| Caco-2 | - | 0.8594 | 85.94% |
| Blood Brain Barrier | - | 0.6750 | 67.50% |
| Human oral bioavailability | - | 0.6286 | 62.86% |
| Subcellular localzation | Lysosomes | 0.6388 | 63.88% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8809 | 88.09% |
| OATP1B3 inhibitior | + | 0.9364 | 93.64% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 0.9750 | 97.50% |
| BSEP inhibitior | + | 0.9169 | 91.69% |
| P-glycoprotein inhibitior | + | 0.7429 | 74.29% |
| P-glycoprotein substrate | + | 0.8629 | 86.29% |
| CYP3A4 substrate | + | 0.7044 | 70.44% |
| CYP2C9 substrate | - | 0.7929 | 79.29% |
| CYP2D6 substrate | - | 0.8494 | 84.94% |
| CYP3A4 inhibition | - | 0.7506 | 75.06% |
| CYP2C9 inhibition | - | 0.8804 | 88.04% |
| CYP2C19 inhibition | - | 0.7904 | 79.04% |
| CYP2D6 inhibition | - | 0.8871 | 88.71% |
| CYP1A2 inhibition | - | 0.8949 | 89.49% |
| CYP2C8 inhibition | - | 0.6025 | 60.25% |
| CYP inhibitory promiscuity | - | 0.9694 | 96.94% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.7700 | 77.00% |
| Carcinogenicity (trinary) | Non-required | 0.6209 | 62.09% |
| Eye corrosion | - | 0.9799 | 97.99% |
| Eye irritation | - | 0.8966 | 89.66% |
| Skin irritation | - | 0.7737 | 77.37% |
| Skin corrosion | - | 0.8992 | 89.92% |
| Ames mutagenesis | - | 0.6000 | 60.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3679 | 36.79% |
| Micronuclear | + | 0.6400 | 64.00% |
| Hepatotoxicity | + | 0.5907 | 59.07% |
| skin sensitisation | - | 0.8552 | 85.52% |
| Respiratory toxicity | + | 0.7667 | 76.67% |
| Reproductive toxicity | + | 0.8000 | 80.00% |
| Mitochondrial toxicity | + | 0.6750 | 67.50% |
| Nephrotoxicity | + | 0.5614 | 56.14% |
| Acute Oral Toxicity (c) | III | 0.6329 | 63.29% |
| Estrogen receptor binding | + | 0.6886 | 68.86% |
| Androgen receptor binding | + | 0.7480 | 74.80% |
| Thyroid receptor binding | + | 0.5940 | 59.40% |
| Glucocorticoid receptor binding | + | 0.6891 | 68.91% |
| Aromatase binding | + | 0.7173 | 71.73% |
| PPAR gamma | + | 0.7778 | 77.78% |
| Honey bee toxicity | - | 0.8370 | 83.70% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.6800 | 68.00% |
| Fish aquatic toxicity | - | 0.7462 | 74.62% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3837 | P07711 | Cathepsin L | 99.52% | 96.61% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.44% | 98.95% |
| CHEMBL3468 | P55210 | Caspase-7 | 99.05% | 95.68% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.97% | 97.25% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.17% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.12% | 96.09% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 97.92% | 98.94% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 97.69% | 92.38% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 97.17% | 96.67% |
| CHEMBL4801 | P29466 | Caspase-1 | 96.84% | 96.85% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.51% | 93.56% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 96.51% | 97.43% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 96.46% | 98.10% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.74% | 94.66% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 95.63% | 94.00% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 94.94% | 96.31% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 94.39% | 96.03% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 93.88% | 98.89% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 93.80% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 93.65% | 91.19% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 93.56% | 95.38% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 93.37% | 97.50% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 92.85% | 92.12% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 92.81% | 99.77% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.65% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.59% | 97.14% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.30% | 96.47% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 91.96% | 100.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 91.37% | 96.67% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 91.32% | 96.95% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 90.91% | 97.64% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 90.55% | 98.24% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 90.37% | 97.21% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.31% | 97.09% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 89.16% | 90.08% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 88.65% | 83.10% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 88.62% | 92.80% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 88.25% | 94.33% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 87.30% | 93.00% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 87.29% | 97.47% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 87.05% | 95.89% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 86.94% | 83.14% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 86.08% | 88.42% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 85.77% | 95.52% |
| CHEMBL1801 | P00747 | Plasminogen | 85.67% | 92.44% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 85.46% | 98.05% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 85.19% | 98.75% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 85.17% | 96.21% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 84.64% | 90.93% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 84.16% | 96.28% |
| CHEMBL5028 | O14672 | ADAM10 | 84.14% | 97.50% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 84.13% | 99.17% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 83.74% | 90.71% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 83.72% | 89.50% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 83.70% | 93.33% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.48% | 96.90% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 83.39% | 93.10% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 83.16% | 94.45% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.91% | 95.50% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 82.27% | 98.57% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 82.19% | 98.77% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 81.97% | 95.71% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 81.91% | 99.17% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 81.84% | 94.45% |
| CHEMBL2140 | P48775 | Tryptophan 2,3-dioxygenase | 81.66% | 98.46% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 81.50% | 97.50% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 81.41% | 95.89% |
| CHEMBL236 | P41143 | Delta opioid receptor | 81.40% | 99.35% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 81.40% | 95.17% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 81.37% | 100.00% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 81.35% | 92.50% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 81.01% | 95.27% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 81.00% | 97.23% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 80.68% | 87.16% |
| CHEMBL3776 | Q14790 | Caspase-8 | 80.63% | 97.06% |
| CHEMBL4461 | Q9NTG7 | NAD-dependent deacetylase sirtuin 3 | 80.50% | 94.36% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 80.10% | 86.67% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139585414 |
| LOTUS | LTS0243383 |
| wikiData | Q77421799 |